SCHEMBL20812971

SCHEMBL20812971

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4cccc(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)c4)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ATM Q13315 1/20 0.49
HDAC4 P56524 1/20 0.40
TSPO P30536 2/20 0.38
KMT2A Q03164 2/20 0.35
IL1R1 P14778 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
APP P05067 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
PTPN1 P18031 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
AKR1C4 P17516 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13620190 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL23439515 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24948354 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL22925492 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24973597 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24947984 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24948444 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24948441 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL24947999 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL6374318 1.00 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10464895-B2 Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-11-05 US disclosed
US-20190077754-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD (JP) 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464895-B2 Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device PIEZO1, RER1, L1CAM L3MBTL1 266/4885KDM4E 2962/4885ATM 2301/4885
US-20190077754-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, RER1, L1CAM L3MBTL1 266/4885KDM4E 2962/4885ATM 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.